DK446389D0 - Cyclohexapeptid, praeparat indeholdende en saadan forbindelse og anvendelse af cyclohexapeptid - Google Patents

Cyclohexapeptid, praeparat indeholdende en saadan forbindelse og anvendelse af cyclohexapeptid

Info

Publication number
DK446389D0
DK446389D0 DK446389A DK446389A DK446389D0 DK 446389 D0 DK446389 D0 DK 446389D0 DK 446389 A DK446389 A DK 446389A DK 446389 A DK446389 A DK 446389A DK 446389 D0 DK446389 D0 DK 446389D0
Authority
DK
Denmark
Prior art keywords
cyclohexapeptide
connection
preparation containing
preparation
Prior art date
Application number
DK446389A
Other languages
English (en)
Other versions
DK446389A (da
DK173802B1 (da
Inventor
Dennis M Schmatz
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK446389D0 publication Critical patent/DK446389D0/da
Publication of DK446389A publication Critical patent/DK446389A/da
Application granted granted Critical
Publication of DK173802B1 publication Critical patent/DK173802B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198904463A 1988-09-12 1989-09-11 Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner DK173802B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US24276788A 1988-09-12 1988-09-12
US24276788 1988-09-12
US24604288A 1988-09-16 1988-09-16
US24604288 1988-09-16
US39888989A 1989-08-30 1989-08-30
US39888989 1989-08-30

Publications (3)

Publication Number Publication Date
DK446389D0 true DK446389D0 (da) 1989-09-11
DK446389A DK446389A (da) 1990-03-13
DK173802B1 DK173802B1 (da) 2001-11-05

Family

ID=27399603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904463A DK173802B1 (da) 1988-09-12 1989-09-11 Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner

Country Status (7)

Country Link
EP (1) EP0359529B1 (da)
JP (1) JPH0725692B2 (da)
CA (1) CA1333150C (da)
DE (1) DE68905119T2 (da)
DK (1) DK173802B1 (da)
ES (1) ES2054017T3 (da)
IE (1) IE892924L (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020063A1 (en) * 1989-06-30 1990-12-31 Robert A. Giacobbe Antibiotic agent
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
IE912046A1 (en) * 1990-06-18 1991-12-18 Fujisawa Pharmaceutical Co New polypeptide compound and a process for preparation¹thereof
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
US5366880A (en) * 1990-12-19 1994-11-22 Merck & Co., Inc. Antibiotic agent
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
TW199162B (da) * 1991-05-09 1993-02-01 Fujisawa Pharmaceutical Co
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
DE69212267T2 (de) * 1991-10-17 1997-01-30 Merck & Co Inc Echinocandin-B-Derivat
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
GB9506372D0 (en) * 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
ES2233070T3 (es) 1998-08-20 2005-06-01 ELI LILLY & COMPANY Sintesis de analogos peptidicos ciclicos modificados en el anillo.
US6506726B1 (en) 1998-12-09 2003-01-14 Eli Lilly And Company Purification of Echinocandin cyclopeptide compounds
EP1582204B1 (en) 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
ATE338060T1 (de) 1999-03-03 2006-09-15 Lilly Co Eli Bildung und anionenaustausch von inneren kristallinen ammoniumsalzen des echinocandins b
IL145187A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin/carbohydrate complexes
CN1345230A (zh) 1999-03-03 2002-04-17 伊莱利利公司 口服ecb药物制剂和药物组合物的制备方法
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803581A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Derivate des tetrahydro-echinocandin b
CA1183127A (en) * 1979-12-13 1985-02-26 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product

Also Published As

Publication number Publication date
DK446389A (da) 1990-03-13
DK173802B1 (da) 2001-11-05
JPH02288837A (ja) 1990-11-28
DE68905119T2 (de) 1993-08-26
EP0359529B1 (en) 1993-03-03
JPH0725692B2 (ja) 1995-03-22
ES2054017T3 (es) 1994-08-01
CA1333150C (en) 1994-11-22
IE892924L (en) 1990-03-12
EP0359529A1 (en) 1990-03-21
DE68905119D1 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
DK446389D0 (da) Cyclohexapeptid, praeparat indeholdende en saadan forbindelse og anvendelse af cyclohexapeptid
DK80591A (da) Retningsboreapparat og fremgangsmaade
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
ATA129389A (de) Zwei-phasen-knochenzement
DK211689A (da) Fluoravermectin- og -milbemycinforbindelser og praeparat indeholdende en saadan forbindelse
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO171591C (no) Forbindelse, biocid blanding og anvendelse
DK246189D0 (da) Antimikrobielt praeparat og anvendelse deraf
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK564189D0 (da) Insecticidt praeparat og insecticid aerosol
DK191787D0 (da) Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK451786D0 (da) Transglucosidase, fremstilling og anvendelse deraf
DK501989D0 (da) Mikrobiocidt praeparat og dettes fremstilling
DK641289D0 (da) Ophthalmologisk praeparat indeholdende et angiotensin-konverterende anzym og carboanhydrase
DK703588D0 (da) Pai-1-blokerende peptider, deres fremstilling og anvendelse
DK592389A (da) Penemderivater, deres fremstilling og anvendelse
NO892676D0 (no) Sialinsyre-bundet oktapeptid og fremstilling derav.
DK674587A (da) Anti-forkoelelses-kit, anti-forkoelelsespraeparat og anvendelse deraf
NO873029D0 (no) Metylenpreparat og anvendelse derav.
DK410089A (da) Substituerede phenylalkylthiophener og dens fremstilling
NO901052L (no) 1h-pyrazol-1-acetamider og fremstilling derav.
IT8821191A0 (it) Peptidi anoressizzanti e ipotensivi.
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
NO904846D0 (no) Amfifile peptider og anvendelse derav.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK